NAD+ × NorthStar Compounds — lab test, September 2026
COA KVR-2026-D6669A matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
VP2F8MQTest results
Not on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 500 mg · Lab measured 514.64 mg
103% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 128.7 mg using the measured mass, against 125 mg on the label — 3% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-D6669A |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of NAD+ from NorthStar Compounds, performed by Kovera Labs on September 1, 2026. Reported purity: 99.483%. Net content: 514.64 mg against 500 mg labeled (103% of label). Batch N52603. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of NAD+ from NorthStar Compounds
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| N12604 | 19 Sept 2026 | Axiom Analytics | 99.97% | 106% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion